Post-stroke cognitive impairment and the possibility of treatment with cellex
Authors:
- 1 January 2016
- journal article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 116 (5) , 38-42
Abstract
To present neuropsychological characteristics of post-stroke cognitive impairment (PSCI) in acute ischemic stroke (IS) and to assess the efficacy of the drug cellex. A comprehensive neuropsychological testing battery was administered to 288 patients with acute IS. In addition to basic therapy, 30 patients received cellexin the dosage of 0.1 mg (1 ml) subcutaneously for 10 days, treatment was started in the acute phase. Multifunctional PSCI were revealed in 87% of patients with acute IS. Impairments of attention, regulatory functions, speech and memory were identified in the majority of patients. More than a third of patients had multifunctional nonamnestic PSCI. Monofunctionalnonamnestic PSCI were found in 5.5% of patients. Isolated deficit of memory was observed in 2% of patients. PSCI with the predominance of mixed character were found mostly in elderly patients. In the group of young and middle-aged patients,there was a decrease in isolated speed reduction or regulation of cognitive activity, combined cognitive impairment was detected in every fourth patient. There was a trend towards an increase in the age of patients withPSCI of the mixed character. An analysis of the efficacy of cellex in acute IS has shown that the drug improves cognitive status as well as the state of neurodynamic, regulatory and visuospatial functions. Therefore, cellex is effective in treatment of PSCI in acute IS.Keywords
This publication has 11 references indexed in Scilit:
- Early- vs late-onset subcortical vascular cognitive impairmentNeurology, 2016
- Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort studyThe Lancet Neurology, 2016
- Influence of Amyloid-β on Cognitive Decline After Stroke/Transient Ischemic AttackStroke, 2015
- The effect of cellex on cognitive and speech impairments in the acute stage of strokeS.S. Korsakov Journal of Neurology and Psychiatry, 2015
- Post-stroke memory impairment among patients with vascular mild cognitive impairmentBMC Neurology, 2014
- Vascular Contributions to Cognitive Impairment and DementiaStroke, 2011
- High frequency of cognitive dysfunction before stroke among older peopleInternational Journal of Geriatric Psychiatry, 2010
- The determinants and longitudinal course of post-stroke mild cognitive impairmentJournal of the International Neuropsychological Society, 2009
- Poststroke Memory Function in Nondemented PatientsStroke, 2007
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004